Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.100
-0.030 (-2.65%)
At close: May 12, 2025, 4:00 PM
1.100
0.00 (0.00%)
After-hours: May 12, 2025, 6:31 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $113.80 million as of May 12, 2025. Its market cap has increased by 245.32% in one year.
Market Cap
113.80M
Enterprise Value
114.27M
1-Year Change
245.32%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $113.80M, a decrease of -77.86%. That is a compound annual growth rate of -34.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 116.91M | 157.55% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.73B |
| Johnson & Johnson | 372.78B |
| UnitedHealth Group | 343.22B |
| AbbVie | 339.20B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.60B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |